Design Therapeutics, Inc. (DSGN)
9.68
+0.67
(+7.44%)
USD |
NASDAQ |
Dec 19, 16:00
9.71
+0.03
(+0.31%)
After-Hours: 20:00
Design Therapeutics EPS Diluted (Quarterly): -0.2984 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bruker Corp. | -0.4111 |
| AVITA Medical, Inc. | -0.4644 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.00M |
| Total Expenses (Quarterly) | 17.00M |
| Enterprise Value | 347.18M |
| Earnings Yield | -12.26% |
| Normalized Earnings Yield | -12.26 |